Clinically, they identified hSpry2 hypermethylation in 26 out of 71 patients with B-cell diffuse lymphoma as well as in 10 out of 13 Burkitt’s lymphomas but in no normal B lymphocytes from 37 healthy individuals. The gene discussed is SPRY2; the disease is Burkitt lymphoma.